Evidence map›Paper›PMID 37151678›Full record

ArticleHeliyon2023

Getu Habte, Sanbato Tamiru, Kedir Eyasu

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Prophylactic impacts ofOpen veterinary journal · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Getu HabteDepartment of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, P.O.Box 1176, Addis Ababa, Ethiopia.
Sanbato TamiruDepartment of Nursing, College of Health Sciences, Mettu University, P.O.Box 318, Mettu, Ethiopia.
Kedir EyasuDepartment of Computer Science, College of Engineering and Technology, Mettu University, P.O.Box 318, Mettu, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Malaria is a public health menace. Resistance to therapeutic armamentarium is impeding its control. Therefore, research targeting the discovery of novel antimalarial drug arsenals is a priority. The important point to begin the search for such drugs is the folkloric medicinal plants. Ripe fruit of Methods: The fruits were extracted using 80% methanol in water. Acute toxicity test was conducted on the extract. Secondary phytochemicals were assessed. The four day suppressive test was employed in mice infected with Results: No toxicity was seen in mice. The crude extract elicited significant suppression (p < 0.05) of the parasite compared to the negative control. The highest parasite suppression (77.37%) was measured at the upper dose. Furthermore, the crude extract significantly (p < 0.05) prevented body weight loss, anemia, reduction in temperature and prolonged the survival time compared to the negative control. Conclusion: This study asserted that the fruit of

Indexed as

AntimalarialIn vivoLagenaria sicerariaMiceP. berghei

Identifiers

PMID37151678
PMCPMC10161574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.